Garrie Richardson - 08 Mar 2024 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Chief Revenue Officer
Signature
/s/ Garrie Richardson
Issuer symbol
BLFS
Transactions as of
08 Mar 2024
Net transactions value
$0
Form type
4
Filing time
12 Mar 2024, 21:45:06 UTC
Previous filing
01 Nov 2023
Next filing
18 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Award +12,516 +12% 117,843 08 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "2023 Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2024 compensation.